Tim Lowery

Interim CEO, KBI BIopharma & Selexis

Tim Lowery serves as interim CEO for KBI Biopharma and Selexis. Tim joined JSR in 1996. Since then, he has supported JSR in several capacities, including as CEO of MBLI, a JSR Life Sciences company. Tim was instrumental in establishing JSR’s life sciences business, spearheading the company’s M&A activities, and global expansion of life science operations.

As President, he is responsible for the development and integration of global strategies among all the JSR Life Sciences companies, which include Crown Bioscience, KBI Biopharma, Inc., MBL and Selexis SA. 

Tim holds a bachelor's degree in Mechanical Engineering from North Carolina State University and an MBA from Duke University’s Fuqua School of Business.